In breast cancer, specific inflammatory signaling cascades – including the NF-κB, JAK-STAT, PI3K-Akt, TGF-β, and CXCR2 pathways – govern neutrophil behavior, modulating immune suppression, angiogenesis, metastasis, and therapy resistance. This evidence concerns the gene TGFB1 and breast cancer.